{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T18:23:08Z","timestamp":1786558988496,"version":"build-2736575974"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T00:00:00Z","timestamp":1745452800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T00:00:00Z","timestamp":1745452800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Misr University for Science & Technology"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Chemistry"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>This work presents two methods for the simultaneous determination of ibuprofen (IBU), paracetamol (PAR), and chlorzoxazone (CHZ) in the presence of three PAR impurities: <jats:italic>p<\/jats:italic>-aminophenol (PAP), <jats:italic>p<\/jats:italic>-nitrophenol (PNP), and <jats:italic>p<\/jats:italic>-chloroacetanilide (PCA). Furthermore, both methods attempt to quantify these hazardous impurities. The first method is a thin layer chromatography densitometric method (TLC), where separation was achieved on silica gel 60 F<jats:sub>254<\/jats:sub> plates using a mobile phase consisting of chloroform, toluene, ethanol, and ammonia (7.0: 1.0: 1.6: 0.2, by volume). Densitometric detection was performed at 220.0\u00a0nm. The second method is a high-performance liquid chromatographic method (HPLC), in which the analytes were separated on an Xterra C8 column (150\u2009\u00d7\u20094.6\u00a0mm, 5\u00a0\u00b5m) using an isocratic mobile phase of acetonitrile and phosphate buffer (pH 7.5) in a 30:70 (v\/v) ratio. The UV detector was set at 220.0\u00a0nm, and the flow rate was maintained at 0.7\u00a0mL\/min. Both methods were validated following ICH guidelines and successfully applied to the determination of IBU, PAR, and CHZ in their commercial tablet formulations. A statistical comparison with a previously reported method confirmed no discernible differences in the results, demonstrating the reliability and accuracy of the proposed techniques.<\/jats:p>","DOI":"10.1186\/s13065-025-01466-6","type":"journal-article","created":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T03:10:15Z","timestamp":1745464215000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Impurity profiling of paracetamol toxic impurities in pharmaceutical combination with ibuprofen and chlorzoxazone using HPLC and TLC densitometric methods"],"prefix":"10.1186","volume":"19","author":[{"given":"Israa A.","family":"Wahba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Said A.","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed S.","family":"Fayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally S.","family":"El-Mosallamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,24]]},"reference":[{"issue":"9","key":"1466_CR1","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1016\/S0039-9140(96)02179-0","volume":"44","author":"S G\u00f6r\u00f6g","year":"1997","unstructured":"G\u00f6r\u00f6g S, Babjak M, Balogh G, Brlik J, Csehi A, Dravecz F, et al. Drug impurity profiling strategies. Talanta. 1997;44(9):1517\u201326.","journal-title":"Talanta"},{"key":"1466_CR2","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.saa.2015.10.007","volume":"154","author":"HW Darwish","year":"2016","unstructured":"Darwish HW, Hassan SA, Salem MY, El-Zeany BA. Advanced stability indicating chemometric methods for quantitation of amlodipine and atorvastatin in their quinary mixture with acidic degradation products. Spectrochim Acta A Mol Biomol Spectrosc. 2016;154:58\u201366.","journal-title":"Spectrochim Acta A Mol Biomol Spectrosc"},{"issue":"1","key":"1466_CR3","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1007\/s10812-019-00799-0","volume":"86","author":"AS Fayed","year":"2019","unstructured":"Fayed AS, Rezk MR, Marzouk HM, Abbas SS. Spectrophotometric assessment of a spectrally overlapping mixture of cinchocaine hydrochloride and betamethasone valerate in the presence of their degradation products. J Appl Spectrosc. 2019;86(1):176\u201386. https:\/\/doi.org\/10.1007\/s10812-019-00799-0.","journal-title":"J Appl Spectrosc"},{"issue":"11","key":"1466_CR4","doi-asserted-by":"publisher","first-page":"2723","DOI":"10.1007\/s11696-019-00824-8","volume":"73","author":"AS Fayed","year":"2019","unstructured":"Fayed AS, Youssif RM, Salama NN, Hendawy HA, Elzanfaly ES. Two-wavelength manipulation stability-indicating spectrophotometric methods for determination of meropenem and ertapenem: greenness consolidation and pharmaceutical product application. Chem Papers. 2019;73(11):2723\u201336. https:\/\/doi.org\/10.1007\/s11696-019-00824-8.","journal-title":"Chem Papers"},{"issue":"6","key":"1466_CR5","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s00604-021-04845-7","volume":"188","author":"SM Eid","year":"2021","unstructured":"Eid SM, Hassan SA, Nashat NW, Elghobashy MR, Abbas SS, Moustafa AAM. Optimization of localized surface plasmon resonance hot spots in surface-enhanced infrared absorption spectroscopy aluminum substrate as an optical sensor coupled to chemometric tools for the purity assay of quinary mixtures. Microchim Acta. 2021;188(6):195.","journal-title":"Microchim Acta"},{"issue":"1","key":"1466_CR6","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1093\/jaoacint\/qsab080","volume":"105","author":"AS Fayed","year":"2022","unstructured":"Fayed AS, Hegazy MA, Kamel EB, Eissa MS. Smart mathematical manipulation of spectral signals: stability indicating, for the estimation of solifenacin succinate: anti-muscarinic drug, in existence of its acid degradation product. J AOAC Int. 2022;105(1):323\u201331.","journal-title":"J AOAC Int"},{"issue":"1","key":"1466_CR7","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1186\/s13065-024-01345-6","volume":"18","author":"MMZ Sharkawi","year":"2024","unstructured":"Sharkawi MMZ, Farid NF, Hassan MH, Hassan SA. New chemometrics-assisted spectrophotometric methods for simultaneous determination of co-formulated drugs montelukast, rupatadine, and desloratadine in their different dosage combinations. BMC Chem. 2024;18(1):232. https:\/\/doi.org\/10.1186\/s13065-024-01345-6.","journal-title":"BMC Chem"},{"issue":"1","key":"1466_CR8","doi-asserted-by":"publisher","first-page":"22406","DOI":"10.1038\/s41598-024-72431-x","volume":"14","author":"SN Ali","year":"2024","unstructured":"Ali SN, Saad SS, Fayed AS, Marzouk HM. Intelligent spectrophotometric resolution platforms for the challenging spectra of ipratropium and fenoterol in their combination inhaler with ecological friendliness assessment. Sci Rep. 2024;14(1):22406. https:\/\/doi.org\/10.1038\/s41598-024-72431-x.","journal-title":"Sci Rep"},{"key":"1466_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2019.112910","volume":"178","author":"MA Gad","year":"2020","unstructured":"Gad MA, Amer SM, Zaazaa HE, Hassan SA. Strategies for stabilizing formulation and QbD assisted development of robust stability indicating method of azilsartan medoxomil\/chlorthalidone. J Pharm Biomed Anal. 2020;178: 112910.","journal-title":"J Pharm Biomed Anal"},{"issue":"8","key":"1466_CR10","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1093\/chromsci\/bmaa031","volume":"58","author":"SA Hassan","year":"2020","unstructured":"Hassan SA, Nashat NW, Elghobashy MR, Abbas SS, Moustafa AAM. Stability-indicating rp-hplc and ce methods for simultaneous determination of bisoprolol and perindopril in pharmaceutical formulation: a comparative study. J Chromatogr Sci. 2020;58(8):747\u201358.","journal-title":"J Chromatogr Sci"},{"issue":"1","key":"1466_CR11","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1093\/chromsci\/bmac111","volume":"62","author":"MS Eissa","year":"2024","unstructured":"Eissa MS, Kamel EB, Hegazy MA, Fayed AS. Expeditive chromatographic methods for quantification of solifenacin succinate along with its official impurity as the possible acid degradation product. J Chromatogr Sci. 2024;62(1):85\u201391. https:\/\/doi.org\/10.1093\/chromsci\/bmac111.","journal-title":"J Chromatogr Sci"},{"key":"1466_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.scp.2023.101358","volume":"37","author":"MA Nessiem","year":"2024","unstructured":"Nessiem MA, Riad SM, Fayed AS, Arafa RM. Comparative study for chiral separation of atracurium besylate isomers: eco-friendly HPLC using Lux cellulose-3 chiral column, and TLC-densitomerty approaches. Sustain Chem Pharm. 2024;37: 101358.","journal-title":"Sustain Chem Pharm"},{"key":"1466_CR13","volume-title":"Stability testing of new drug substances and products Q1A(R2)","author":"ICH","year":"2003","unstructured":"ICH. Stability testing of new drug substances and products Q1A(R2). ICH; 2003."},{"key":"1466_CR14","unstructured":"ICH. Guideline for evaluation of stability data, Q1E."},{"key":"1466_CR15","volume-title":"impurities in new drug substances Q3A (R2)","author":"ICH","year":"2006","unstructured":"ICH. impurities in new drug substances Q3A (R2). ICH; 2006."},{"key":"1466_CR16","unstructured":"ICH. Genotoxicity testing and data interpretation for pharmaceuticals intended for human use, ICH S2 (R1)."},{"key":"1466_CR17","volume-title":"Clarke\u2019s analysis of drugs and poisons","author":"AC Moffat","year":"2011","unstructured":"Moffat AC, Osselton MD, Widdop B, Watts J. Clarke\u2019s analysis of drugs and poisons, vol. 3. London: Pharmaceutical press; 2011."},{"key":"1466_CR18","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s10787-009-0016-x","volume":"17","author":"KD Rainsford","year":"2009","unstructured":"Rainsford KD. Ibuprofen: pharmacology, efficacy and safety. Inflammopharmacology. 2009;17:275\u2013342.","journal-title":"Inflammopharmacology"},{"issue":"1","key":"1466_CR19","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1097\/00045391-200501000-00008","volume":"12","author":"GG Graham","year":"2005","unstructured":"Graham GG, Scott KF. Mechanism of action of paracetamol. Am J Ther. 2005;12(1):46\u201355.","journal-title":"Am J Ther"},{"issue":"1","key":"1466_CR20","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/S0006-8993(02)03730-7","volume":"959","author":"YC Liu","year":"2003","unstructured":"Liu YC, Lo YK, Wu SN. Stimulatory effects of chlorzoxazone, a centrally acting muscle relaxant, on large conductance calcium-activated potassium channels in pituitary GH3 cells. Brain Res. 2003;959(1):86\u201397.","journal-title":"Brain Res"},{"key":"1466_CR21","volume-title":"Lippincott\u2019s illustrated reviews: pharmacology","author":"RA Harvey","year":"2012","unstructured":"Harvey RA, Champe PC, Mycek MJ, Gertner SB, Perper MM. Lippincott\u2019s illustrated reviews: pharmacology, vol. 526. Wolters Kluwer Health\/Lippincott Williams & Wilkins; 2012."},{"key":"1466_CR22","volume-title":"The stationery office","author":"British Pharmacopoeia","year":"2023","unstructured":"British Pharmacopoeia. The stationery office, vol. 1. British Pharmacopoeia; 2023."},{"issue":"1","key":"1466_CR23","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1093\/jaoacint\/qsab119","volume":"105","author":"JF Farid","year":"2022","unstructured":"Farid JF, Mostafa NM, Fayez YM, Essam HM. Systemic optimization and validation of normal and reversed-phase eco-friendly chromatographic methods for simultaneous determination of paracetamol and phenylephrine hydrochloride in the presence of paracetamol impurities. J AOAC Int. 2022;105(1):26\u201333.","journal-title":"J AOAC Int"},{"issue":"1","key":"1466_CR24","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s13065-022-00904-z","volume":"16","author":"MA Abdel Rahman","year":"2022","unstructured":"Abdel Rahman MA, Elghobashy MR, Zaazaa HE, Atty SA, El-Mosallamy SS. Validated HPLC\u2013PDA methodology utilized for simultaneous determination of Etoricoxib and Paracetamol in the presence of Paracetamol toxic impurities. BMC Chem. 2022;16(1):108.","journal-title":"BMC Chem"},{"issue":"2","key":"1466_CR25","doi-asserted-by":"publisher","DOI":"10.1002\/bmc.5539","volume":"37","author":"SA Tawfik","year":"2023","unstructured":"Tawfik SA, El-Ragehy NA, Hegazy MA, Sedik GA. A reversed-phase-high performance liquid chromatography method for simultaneous determination of paracetamol, caffeine, drotaverine HCl and their related impurities with dissolution profiling of their tablets and greenness profile assessment. Biomed Chromatogr. 2023;37(2): e5539.","journal-title":"Biomed Chromatogr"},{"issue":"3","key":"1466_CR26","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1093\/chromsci\/bmz094","volume":"58","author":"SA Boltia","year":"2020","unstructured":"Boltia SA, Soudi AT, Elzanfaly ES, Zaazaa HE. Development and validation of chromatographic methods for simultaneous determination of paracetamol, orphenadrine citrate and caffeine in presence of p-aminophenol; quantification of p-aminophenol nephrotoxic impurity using lc\u2013ms\/ms. J Chromatogr Sci. 2020;58(3):223\u201333.","journal-title":"J Chromatogr Sci"},{"issue":"1","key":"1466_CR27","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s13065-023-01059-1","volume":"17","author":"SA Hassan","year":"2023","unstructured":"Hassan SA, Fekry RA, Fayez YM, Kelani KM. Continuous wavelet transform for solving the problem of minor components in quantitation of pharmaceuticals: a case study on the mixture of ibuprofen and phenylephrine with its degradation products. BMC Chem. 2023;17(1):140.","journal-title":"BMC Chem"},{"issue":"1","key":"1466_CR28","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/s13065-023-01056-4","volume":"17","author":"KM Kelani","year":"2023","unstructured":"Kelani KM, Fayez YM, Abdel-Raoof AM, Fekry RA, Hassan SA. Development of an eco-friendly HPLC method for the stability indicating assay of binary mixture of ibuprofen and phenylephrine. BMC Chem. 2023;17(1):141.","journal-title":"BMC Chem"},{"issue":"3","key":"1466_CR29","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1556\/1326.2020.00793","volume":"33","author":"SA Hassan","year":"2021","unstructured":"Hassan SA, Ibrahim N, Elzanfaly ES, El-Gendy AE. Analytical quality by design approach for the control of potentially counterfeit chloroquine with some NSAIDS using HPLC with fluorescence detection in pharmaceutical preparation and breast milk. Acta Chromatogr. 2021;33(3):234\u201344.","journal-title":"Acta Chromatogr"},{"issue":"5","key":"1466_CR30","first-page":"1","volume":"8","author":"IOA Reid","year":"2024","unstructured":"Reid IOA, Sam AK. Smart spectrophotometric methods for the determination of chlorzoxazone and paracetamol form tablets. Int J Res AYUSH Pharm Sci. 2024;8(5):1\u20138.","journal-title":"Int J Res AYUSH Pharm Sci"},{"issue":"1","key":"1466_CR31","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1038\/s41598-024-52450-4","volume":"14","author":"KM Kelani","year":"2024","unstructured":"Kelani KM, Fekry RA, Fayez YM, Hassan SA. Advanced chemometric methods for simultaneous quantitation of caffeine, codeine, paracetamol, and p-aminophenol in their quaternary mixture. Sci Rep. 2024;14(1):2085.","journal-title":"Sci Rep"},{"key":"1466_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.saa.2024.123891","volume":"310","author":"J Mendonsa","year":"2024","unstructured":"Mendonsa J, Gandhi S, Mahajan A. Quantification of ternary mixture of paracetamol, chlorzoxazone and ibuprofen present in tablet dosage form using ratio subtraction spectrophotometric approaches. Spectrochim Acta A Mol Biomol Spectrosc. 2024;310: 123891.","journal-title":"Spectrochim Acta A Mol Biomol Spectrosc"},{"issue":"2","key":"1466_CR33","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1080\/222979282000.10648258","volume":"2","author":"R Joshi","year":"2012","unstructured":"Joshi R, Pawar N, Sawant R, Gaikwad P. Simultaneous estimation of paracetamol, chlorzoxazone and ibuprofen by validated spectrophotometric methods. Anal Chem Lett. 2012;2(2):118\u201324.","journal-title":"Anal Chem Lett"},{"issue":"2","key":"1466_CR34","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/S0039-9140(97)00153-7","volume":"45","author":"VR Bari","year":"1997","unstructured":"Bari VR, Dhorda UJ, Sundaresan M. A simultaneous packed column supercritical fluid chromatographic method for ibuprofen, chlorzoxazone and acetaminophen in bulk and dosage forms. Talanta. 1997;45(2):297\u2013302.","journal-title":"Talanta"},{"issue":"6","key":"1466_CR35","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1016\/S0039-9140(98)00043-5","volume":"46","author":"S Ravisankar","year":"1998","unstructured":"Ravisankar S, Vasudevan M, Gandhimathi M, Suresh B. Reversed-phase HPLC method for the estimation of acetaminophen, ibuprofen and chlorzoxazone in formulations. Talanta. 1998;46(6):1577\u201381.","journal-title":"Talanta"},{"issue":"2","key":"1466_CR36","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1093\/chromsci\/bmaa088","volume":"59","author":"H Ibrahim","year":"2021","unstructured":"Ibrahim H, Hamdy AM, Merey HA, Saad AS. Simultaneous determination of paracetamol, propyphenazone and caffeine in presence of paracetamol impurities using dual-mode gradient HPLC and TLC densitometry methods. J Chromatogr Sci. 2021;59(2):140\u20137.","journal-title":"J Chromatogr Sci"},{"issue":"9","key":"1466_CR37","doi-asserted-by":"publisher","DOI":"10.1002\/bmc.4598","volume":"33","author":"NS Abdelwahab","year":"2019","unstructured":"Abdelwahab NS, Abdelrahman MM, Boshra JM, Taha AA. Different stability-indicating chromatographic methods for specific determination of paracetamol, dantrolene sodium, their toxic impurities and degradation products. Biomed Chromatogr. 2019;33(9): e4598.","journal-title":"Biomed Chromatogr"},{"key":"1466_CR38","unstructured":"ICH I. Q2 (R1): validation of analytical procedures: text and methodology. In: International conference on harmonization, Geneva; 2005."},{"key":"1466_CR39","volume-title":"High performance liquid chromatography & capillary electrophoresis: principles and practices","author":"A Weston","year":"1997","unstructured":"Weston A, Brown PR. High performance liquid chromatography & capillary electrophoresis: principles and practices. Elsevier; 1997."}],"container-title":["BMC Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13065-025-01466-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13065-025-01466-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13065-025-01466-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T03:10:21Z","timestamp":1745464221000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcchem.biomedcentral.com\/articles\/10.1186\/s13065-025-01466-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,24]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1466"],"URL":"https:\/\/doi.org\/10.1186\/s13065-025-01466-6","relation":{},"ISSN":["2661-801X"],"issn-type":[{"value":"2661-801X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,24]]},"assertion":[{"value":"30 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"110"}}